Success Story: NIW Approved Without RFE! Our Firm Helped an Ethiopian Research Professor Secure Success
Client’s Testimonial:
“I want to express my appreciation for the overall case preparation process. The consultation was efficient, and my inquiries were met with timely, tailored responses. The team is well-organized and excels in file preparation, drafting recommendations, and evaluating evidence. They genuinely considered my comments and crafted the petition letter with care and professionalism. Overall, I had an excellent experience and highly recommend your services to anyone seeking a trusted immigration lawyer.”
On January 13th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Professor in the Field of Biotechnologies (Approval Notice).
General Field: Biotechnologies
Position at the Time of Case Filing: Research Professor
Country of Origin: Ethiopia
Country of Residence at the Time of Filing: Republic of Korea
Approval Notice Date: January 13th, 2025
Processing Time: 2 months, 27 days (Premium Processing Upgrade Requested)
Case Summary:
At North America Immigration Law Group, we are proud to share the success story of an exceptional researcher whose dedication to advancing the field of biotechnologies recently earned an I-140 National Interest Waiver (NIW) approval. Through strategic case preparation and precise presentation of evidence, our team helped secure approval for this case, reinforcing the client’s crucial role in advancing U.S. innovation in biotechnology and healthcare.
Client Background and Field
Our client holds a Ph.D. in biological engineering and is an established expert in biotechnologies. The client’s research integrates advanced computational techniques and artificial intelligence (AI) to decode complex biological mechanisms, identify new drug targets, and streamline drug discovery processes. This line of work is fundamental to improving healthcare outcomes and promoting innovation across the biotechnology sector — an area formally recognized by the U.S. government as a critical and emerging technology essential for maintaining national competitiveness.
Petition Strategy and Case Highlights
Upon receiving this case, our legal team conducted a comprehensive evaluation of the client’s qualifications and scholarly record. We emphasized the national importance of the client’s ongoing research, aligning it with federal initiatives promoting AI-driven drug discovery and biomanufacturing technologies.
To demonstrate the client’s strong standing in the field, we presented:
- 8 peer-reviewed journal articles (6 first-authored) and 2 first-authored abstracts, published in top-tier scientific venues in biotechnology and pharmacology.
- 97 total citations, reflecting the global impact and reliance on the client’s research by independent scholars and research groups.
- At least 10 completed peer reviews for recognized scientific journals — a clear indicator of the client’s expertise and trust within the academic community.
- Documentation of major research funding from the Ministry of Innovation and Technology (MinT), underscoring both the credibility and societal relevance of the client’s work.
Expert Endorsements
To reinforce the petition, we included four detailed recommendation letters from distinguished researchers across multiple countries. These experts emphasized the client’s pioneering use of computational and genomic approaches for drug discovery and described the client’s findings as “foundational to future AI-assisted pharmaceutical innovation.”
“As a highly prominent researcher in biotechnologies, [Client] has contributed significantly to the treatment efficacy of complex diseases such as AML. His work is particularly valuable in the context of the limited treatment options and the high fatality rate of AML. It is clear that [Client’s] work is of great value to the field and that he is an irreplaceable presence in the research sphere.”
Case Outcome
Our firm’s meticulous presentation of the client’s research impact and alignment with national interests led to a successful NIW approval in just 2 months and 27 days. This result reflects both the client’s remarkable achievements and our commitment to securing favorable outcomes for researchers shaping the future of science and technology in the United States.
We are honored to have supported this client’s immigration journey and look forward to witnessing continued breakthroughs in computational biotechnology that enhance global health and scientific progress.